CN105797106A - 一种用于治疗心脏室性早搏的中药饮剂及制备方法 - Google Patents
一种用于治疗心脏室性早搏的中药饮剂及制备方法 Download PDFInfo
- Publication number
- CN105797106A CN105797106A CN201610239725.5A CN201610239725A CN105797106A CN 105797106 A CN105797106 A CN 105797106A CN 201610239725 A CN201610239725 A CN 201610239725A CN 105797106 A CN105797106 A CN 105797106A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- fructus
- chinese medicine
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 62
- 230000002861 ventricular Effects 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- 208000000418 Premature Cardiac Complexe Diseases 0.000 title abstract description 7
- 210000002216 Heart Anatomy 0.000 claims abstract description 41
- 239000000843 powder Substances 0.000 claims abstract description 34
- 241000218176 Corydalis Species 0.000 claims abstract description 16
- 210000000582 Semen Anatomy 0.000 claims abstract description 16
- 241000721183 Circaea Species 0.000 claims abstract description 15
- 239000000203 mixture Substances 0.000 claims description 24
- 230000002028 premature Effects 0.000 claims description 22
- 241000222336 Ganoderma Species 0.000 claims description 16
- 241000921449 Rhodobryum roseum Species 0.000 claims description 15
- 238000010410 dusting Methods 0.000 claims description 15
- 238000010298 pulverizing process Methods 0.000 claims description 15
- 240000000218 Cannabis sativa Species 0.000 claims description 14
- 241000282373 Panthera pardus Species 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 238000004140 cleaning Methods 0.000 claims description 12
- 238000009835 boiling Methods 0.000 claims description 11
- 239000004615 ingredient Substances 0.000 claims description 11
- 238000007654 immersion Methods 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 9
- 238000001816 cooling Methods 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 5
- -1 after dry Substances 0.000 claims description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 claims description 3
- 230000000240 adjuvant Effects 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000001704 evaporation Methods 0.000 claims description 3
- 238000007710 freezing Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 239000008280 blood Substances 0.000 abstract description 49
- 210000004369 Blood Anatomy 0.000 abstract description 43
- 230000000694 effects Effects 0.000 abstract description 32
- 230000001737 promoting Effects 0.000 abstract description 28
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 22
- 230000017531 blood circulation Effects 0.000 abstract description 12
- 238000004519 manufacturing process Methods 0.000 abstract description 12
- 210000001124 Body Fluids Anatomy 0.000 abstract description 11
- 239000010839 body fluid Substances 0.000 abstract description 11
- 238000010792 warming Methods 0.000 abstract description 11
- 208000001431 Psychomotor Agitation Diseases 0.000 abstract description 10
- 206010038743 Restlessness Diseases 0.000 abstract description 10
- 230000001105 regulatory Effects 0.000 abstract description 10
- 230000001603 reducing Effects 0.000 abstract description 7
- 206010016807 Fluid retention Diseases 0.000 abstract description 4
- 241000721047 Danaus plexippus Species 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 231100000486 side effect Toxicity 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 240000008397 Ganoderma lucidum Species 0.000 abstract description 2
- 235000001637 Ganoderma lucidum Nutrition 0.000 abstract description 2
- 230000001914 calming Effects 0.000 abstract description 2
- 235000006463 Brassica alba Nutrition 0.000 abstract 1
- 244000140786 Brassica hirta Species 0.000 abstract 1
- 241001061906 Caragana Species 0.000 abstract 1
- 241001040831 Carex siderosticta Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 240000004499 Cinnamomum aromaticum Species 0.000 abstract 1
- 241000694498 Citrus limonimedica Species 0.000 abstract 1
- 240000005389 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 240000006509 Gynostemma pentaphyllum Species 0.000 abstract 1
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 240000002948 Ophiopogon intermedius Species 0.000 abstract 1
- 241001038562 Pseudostellaria heterophylla Species 0.000 abstract 1
- 241000921453 Rhodobryum Species 0.000 abstract 1
- 241001533104 Tribulus terrestris Species 0.000 abstract 1
- 235000008326 Trichosanthes anguina Nutrition 0.000 abstract 1
- 240000004013 Trichosanthes cucumerina Species 0.000 abstract 1
- 240000007329 Zingiber officinale Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 241001247821 Ziziphus Species 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 231100000494 adverse effect Toxicity 0.000 abstract 1
- 235000020639 clam Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 235000014063 licorice root Nutrition 0.000 abstract 1
- 210000000952 Spleen Anatomy 0.000 description 37
- 210000004072 Lung Anatomy 0.000 description 32
- 210000002784 Stomach Anatomy 0.000 description 23
- 210000000214 Mouth Anatomy 0.000 description 22
- 201000010099 disease Diseases 0.000 description 21
- 206010011224 Cough Diseases 0.000 description 19
- 210000004185 Liver Anatomy 0.000 description 17
- 208000002193 Pain Diseases 0.000 description 16
- 230000036407 pain Effects 0.000 description 16
- 206010022437 Insomnia Diseases 0.000 description 12
- 235000009508 confectionery Nutrition 0.000 description 12
- 230000002936 tranquilizing Effects 0.000 description 12
- 210000003734 Kidney Anatomy 0.000 description 10
- 206010033557 Palpitations Diseases 0.000 description 10
- 229940079593 drugs Drugs 0.000 description 9
- 206010016256 Fatigue Diseases 0.000 description 8
- 210000000038 chest Anatomy 0.000 description 8
- 208000006820 Arthralgia Diseases 0.000 description 7
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 239000007789 gas Substances 0.000 description 7
- 206010003549 Asthenia Diseases 0.000 description 6
- 208000002173 Dizziness Diseases 0.000 description 6
- 206010000077 Abdominal mass Diseases 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 5
- 210000004351 Coronary Vessels Anatomy 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 230000001276 controlling effect Effects 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 210000001015 Abdomen Anatomy 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 208000006673 Asthma Diseases 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 241000668709 Dipterocarpus costatus Species 0.000 description 4
- 210000003205 Muscles Anatomy 0.000 description 4
- 208000003067 Myocardial Ischemia Diseases 0.000 description 4
- 231100000614 Poison Toxicity 0.000 description 4
- 201000000736 amenorrhea Diseases 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 201000008286 diarrhea Diseases 0.000 description 4
- 230000000414 obstructive Effects 0.000 description 4
- 230000001717 pathogenic Effects 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 230000001502 supplementation Effects 0.000 description 4
- 206010002383 Angina pectoris Diseases 0.000 description 3
- 208000004981 Coronary Disease Diseases 0.000 description 3
- 206010061428 Decreased appetite Diseases 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 206010015856 Extrasystoles Diseases 0.000 description 3
- 210000003414 Extremities Anatomy 0.000 description 3
- 208000000616 Hemoptysis Diseases 0.000 description 3
- 210000000936 Intestines Anatomy 0.000 description 3
- 206010025482 Malaise Diseases 0.000 description 3
- 208000002720 Malnutrition Diseases 0.000 description 3
- 206010027327 Menstrual disease Diseases 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- 208000007443 Neurasthenia Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 230000000844 anti-bacterial Effects 0.000 description 3
- 230000003110 anti-inflammatory Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000000747 cardiac effect Effects 0.000 description 3
- 230000001684 chronic Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 235000000824 malnutrition Nutrition 0.000 description 3
- 230000001071 malnutrition Effects 0.000 description 3
- 210000004914 menses Anatomy 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 230000025627 positive regulation of urine volume Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000033764 rhythmic process Effects 0.000 description 3
- 235000017709 saponins Nutrition 0.000 description 3
- 230000002522 swelling Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N (3β)-Cholest-5-en-3-ol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000269 Abscess Diseases 0.000 description 2
- IYIKLHRQXLHMJQ-UHFFFAOYSA-N Amiodarone Chemical compound CCCCC=1OC2=CC=CC=C2C=1C(=O)C1=CC(I)=C(OCCN(CC)CC)C(I)=C1 IYIKLHRQXLHMJQ-UHFFFAOYSA-N 0.000 description 2
- 229960005260 Amiodarone Drugs 0.000 description 2
- 206010003119 Arrhythmia Diseases 0.000 description 2
- 210000004204 Blood Vessels Anatomy 0.000 description 2
- 210000000988 Bone and Bones Anatomy 0.000 description 2
- 210000000481 Breast Anatomy 0.000 description 2
- 206010007521 Cardiac arrhythmias Diseases 0.000 description 2
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N Cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 2
- 206010013781 Dry mouth Diseases 0.000 description 2
- 208000001848 Dysentery Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000005577 Gastroenteritis Diseases 0.000 description 2
- 206010019233 Headache Diseases 0.000 description 2
- 210000001624 Hip Anatomy 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010062060 Hyperlipidaemia Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000009856 Lung Disease Diseases 0.000 description 2
- 230000036740 Metabolism Effects 0.000 description 2
- VLPIATFUUWWMKC-UHFFFAOYSA-N Mexiletine Chemical compound CC(N)COC1=C(C)C=CC=C1C VLPIATFUUWWMKC-UHFFFAOYSA-N 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010033425 Pain in extremity Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- JWHAUXFOSRPERK-UHFFFAOYSA-N Propafenone Chemical compound CCCNCC(O)COC1=CC=CC=C1C(=O)CCC1=CC=CC=C1 JWHAUXFOSRPERK-UHFFFAOYSA-N 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 206010040872 Skin infection Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 206010042772 Syncope Diseases 0.000 description 2
- 208000008203 Tachypnea Diseases 0.000 description 2
- 206010043089 Tachypnoea Diseases 0.000 description 2
- 210000002435 Tendons Anatomy 0.000 description 2
- 206010044302 Tracheitis Diseases 0.000 description 2
- 210000003932 Urinary Bladder Anatomy 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 230000003143 atherosclerotic Effects 0.000 description 2
- 239000002876 beta blocker Substances 0.000 description 2
- 201000008739 coronary artery disease Diseases 0.000 description 2
- 230000003247 decreasing Effects 0.000 description 2
- 230000003203 everyday Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000002496 gastric Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 201000010238 heart disease Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000000302 ischemic Effects 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000035786 metabolism Effects 0.000 description 2
- 229960003404 mexiletine Drugs 0.000 description 2
- 230000003000 nontoxic Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 201000008125 pain agnosia Diseases 0.000 description 2
- 244000052769 pathogens Species 0.000 description 2
- 229960000203 propafenone Drugs 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000002269 spontaneous Effects 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 201000010874 syndrome Diseases 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 230000002588 toxic Effects 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2S)-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 1
- JWZZKOKVBUJMES-UHFFFAOYSA-N 4-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}benzene-1,2-diol Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 210000000577 Adipose Tissue Anatomy 0.000 description 1
- 210000004100 Adrenal Glands Anatomy 0.000 description 1
- 206010001902 Amaurosis Diseases 0.000 description 1
- 208000002894 Beriberi Diseases 0.000 description 1
- 206010006451 Bronchitis Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 229940107161 Cholesterol Drugs 0.000 description 1
- 206010062317 Condyloma latum Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 208000000264 Deglutition Disorders Diseases 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 206010013950 Dysphagia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010013990 Dysuria Diseases 0.000 description 1
- 208000001780 Epistaxis Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010016286 Febrile disease Diseases 0.000 description 1
- 210000000232 Gallbladder Anatomy 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010067715 Gastrointestinal sounds abnormal Diseases 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010018987 Haemorrhage Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000002672 Hepatitis B Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010020852 Hypertonia Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 206010022114 Injury Diseases 0.000 description 1
- 229940039009 Isoproterenol Drugs 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 206010028334 Muscle spasms Diseases 0.000 description 1
- 210000002464 Muscle, Smooth, Vascular Anatomy 0.000 description 1
- 208000010125 Myocardial Infarction Diseases 0.000 description 1
- 210000004165 Myocardium Anatomy 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 210000003516 Pericardium Anatomy 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 208000008425 Protein Deficiency Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010062104 Renal mass Diseases 0.000 description 1
- 206010072736 Rheumatic disease Diseases 0.000 description 1
- 206010040943 Skin ulcer Diseases 0.000 description 1
- 208000010110 Spontaneous Platelet Aggregation Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 210000002700 Urine Anatomy 0.000 description 1
- 206010047281 Ventricular arrhythmia Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 210000002268 Wool Anatomy 0.000 description 1
- 230000003187 abdominal Effects 0.000 description 1
- 230000003213 activating Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 229930013930 alkaloids Natural products 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic Effects 0.000 description 1
- 230000000954 anitussive Effects 0.000 description 1
- 230000003042 antagnostic Effects 0.000 description 1
- 230000002429 anti-coagulation Effects 0.000 description 1
- 230000001773 anti-convulsant Effects 0.000 description 1
- 230000000845 anti-microbial Effects 0.000 description 1
- 230000000702 anti-platelet Effects 0.000 description 1
- 230000001139 anti-pruritic Effects 0.000 description 1
- 230000001754 anti-pyretic Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding Effects 0.000 description 1
- 231100000319 bleeding Toxicity 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000002612 cardiopulmonary Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000004027 cells Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- 201000002574 conversion disease Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001066 destructive Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing Effects 0.000 description 1
- 230000003419 expectorant Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 235000021285 flavonoid Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 229930003935 flavonoids Natural products 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 235000019525 fullness Nutrition 0.000 description 1
- 150000004676 glycans Polymers 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000000819 hypertonic solution Substances 0.000 description 1
- 230000000147 hypnotic Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal Effects 0.000 description 1
- 229960001317 isoprenaline Drugs 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 201000008197 laryngitis Diseases 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000001617 migratory Effects 0.000 description 1
- 101710031899 moon Proteins 0.000 description 1
- 230000002107 myocardial Effects 0.000 description 1
- 230000000422 nocturnal Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 210000000056 organs Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000001681 protective Effects 0.000 description 1
- 230000001047 pyretic Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003014 reinforcing Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000552 rheumatic Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000000391 smoking Effects 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000002048 spasmolytic Effects 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 230000003393 splenic Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 210000001519 tissues Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/10—Bryophyta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/86—Violaceae (Violet family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Abstract
本发明公开了一种用于治疗心脏室性早搏的中药饮剂及制备方法,属中药领域。本发明药物有效成分的原料组成为:绞股蓝、桂枝、太子参、麦门冬、蛤蜊粉、丹参、豹皮菇、棒棒草、柠条根、大枣、短柄五加、瓜蒌、延胡索、甘草、崖棕根、白芥子、白蒺藜、佛手、高山露珠草、干姜、回心草、莲肉、黄花堇菜、灵芝。本发明选用药材符合君臣左使之理,针对病因对症下药,有益气养血、养阴生津、活血化瘀、温通经脉、化痰逐饮、理气解郁、清心除烦、养心安神之功效,吸收效果好,疗效显著,无毒副作用及临床不良反应,经临床验证对室性早搏治愈率较高。
Description
所属技术领域
本发明涉及中药领域,尤其涉及一种用于治疗心脏室性早搏的中药饮剂及制备方法。
背景技术
室性早搏是早于基础心律(多为窦性心律)提前出现的室性冲动。室性早搏是临床上非常常见的心律失常,其发生人群相当广泛,包括正常健康人群和各种心脏病患者。室性早搏的临床症状有很大的变异性,从无症状,轻微心悸不适,到早搏触发恶性室性心律失常致晕厥或黑蒙,且其临床症状与预后并无平行关系。在我国,由于社会竞争的日趋激烈以及不良生活习惯的影响,发病率有逐年增高趋势,因此,如何有效治疗室性早搏,减少患者发病率、死亡率,已引起了社会的广泛关注。
目前,西医对室性早搏患者主要使用美西律、β受体阻滞剂、普罗帕酮、胺碘酮等药物进行治疗,但这样药物治标不治本,且长期服用其副作用发生率高。
室性早搏属西医现代病名,属心电图诊断。中医自古无此诊断,但从中症状上看,归属于中医学"心悸"、"怔忡"范畴,多因气血阴阳亏虚,痰饮瘀血阻滞,心脉痹阻,心失所养,以自觉心中急剧跳动、惊慌不安、不能自主为主要表现的一种病证。因此本发明根据病因对症下药,具有益气养血、养阴生津、活血化瘀、温通经脉、化痰逐饮、理气解郁、清心除烦、养心安神之功效,吸收效果好,疗效显著,无毒副作用及临床不良反应,经临床验证对室性早搏治愈率较高。
发明内容
本发明提供了一种用于治疗心脏室性早搏的中药饮剂及制备方法,具有益气养血、养阴生津、活血化瘀、温通经脉、化痰逐饮、理气解郁、清心除烦、养心安神之功效,治病求源标本兼治,对各种原因引起的室性早搏均具有很好的疗效。
为实现上述目的,本发明的技术方案实施如下:
一种用于治疗心脏室性早搏的中药饮剂,制成所述药物有效成分的原料组成及重量份数为:
绞股蓝69~83份、桂枝66~80份、太子参63~77份、麦门冬60~74份、
蛤蜊粉56~71份、丹参53~68份、豹皮菇50~65份、棒棒草47~62份、
柠条根44~58份、大枣41~54份、短柄五加38~51份、瓜蒌35~48份、
延胡索32~45份、甘草29~42份、崖棕根26~38份、白芥子22~35份、
白蒺藜19~32份、佛手16~28份、高山露珠草12~25份、干姜9~21份、
回心草7~18份、莲肉5~15份、黄花堇菜3~12份、灵芝1~9份。
制成所述药物有效成分的原料组成及重量份数为:
绞股蓝72~80份、桂枝69~77份、太子参66~74份、麦门冬63~71份、
蛤蜊粉59~68份、丹参56~65份、豹皮菇53~62份、棒棒草50~59份、
柠条根47~55份、大枣44~51份、短柄五加41~48份、瓜蒌38~45份、
延胡索35~42份、甘草32~39份、崖棕根29~35份、白芥子25~32份、
白蒺藜22~29份、佛手19~25份、高山露珠草15~21份、干姜12~18份、
回心草9~15份、莲肉7~12份、黄花堇菜5~10份、灵芝2~7份。
制成所述药物有效成分的原料组成及重量份数为:
绞股蓝76份、桂枝73份、太子参70份、麦门冬67份、
蛤蜊粉64份、丹参60份、豹皮菇57份、棒棒草54份、
柠条根51份、大枣48份、短柄五加44份、瓜蒌41份、
延胡索38份、甘草35份、崖棕根32份、白芥子29份、
白蒺藜26份、佛手22份、高山露珠草18份、干姜15份、
回心草12份、莲肉9份、黄花堇菜7份、灵芝4份。
一种用于治疗心脏室性早搏的中药饮剂的制备方法,包括以下工艺步骤:
(1)将绞股蓝、桂枝、太子参、麦门冬、蛤蜊粉、豹皮菇、棒棒草、柠条根、大枣、短柄五加、瓜蒌、崖棕根、白芥子、佛手、高山露珠草、干姜、回心草、莲肉、黄花堇菜洗净、晾干后混合均匀,放入容器中,在容器中加入6~8倍量的水,加热煮沸2~3小时,冷却后取浸液;在剩余的药渣中再加入4~6倍量的水,加热煮沸1~2小时,冷却后取浸液;合并两次所得浸液,加热,蒸发浓缩为相对密度1.15~1.25的稠膏,备用;
(2)取丹参片,加黄酒拌匀,闷润至透,置锅内,用文火炒干,取出放凉,粉碎研末,过100目细筛,得细粉,备用;
(3)取净延胡索片或碎块,加黄酒拌匀,闷透,置锅内用文火加热,炒干,取出放凉,粉碎研末,过100目细筛,得细粉,备用;
(4)取净甘草片,加入炼熟的蜂蜜与少许开水,拌匀后稍闷,置炒制容器内,文火炒至深黄色,不粘手时取出,放凉,粉碎研末,过100目细筛,得细粉,备用;
(5)取去刺的白蒺藜,用盐水拌匀,闷透,置锅内用文火炒至微黄色,取出,晒干,粉碎研末,过100目细筛,得细粉,备用;
(6)将灵芝洗净晒干,粉碎研末,过100目细筛,得细粉,备用;
(7)将步骤(1)所得的稠膏,与步骤(3)、步骤(4)、步骤(5)、步骤(6)中所得的细粉混合,加辅料蔗糖和糊精混合均匀制成颗粒,干燥、整粒后,封装成每袋10g的中药冲剂。
本发明所用中药的药性如下:
绞股蓝:味苦;微甘;性凉。归肺;脾;肾经。养心健脾、益气和血、清热解毒、祛痰化瘀。主治:体虚乏力;虚劳失精;白细胞减少症;高脂血症;病毒性肝炎;慢性胃肠炎;慢性气管炎。《明清中医临证小丛书》中记载:绞股蓝补气养阴,清肺化痰,养心安神,生精固精。现代医学研究发现,绞股蓝主要有效成分为多糖类、黄酮类、皂苷类及微量元素类,其功效主要是促进人体脂肪类物质代谢、营养人体细胞,同时具有不错的解毒消炎作用,广泛应用于高血脂、脂肪肝、肥胖、便秘、失眠、乙肝、慢性呼吸道炎症(咽喉炎、肠胃炎等)的治疗与保健。
桂枝:味辛;甘;性温。入膀胱;心;肺经。散寒解表;温通经脉;通阳化气。主治风寒表证;寒湿痹痛;四肢厥冷;经闭痛经;癓瘕结块;胸痹;心悸;痰饮;小便不利。《长沙药解》载:“入肝家而行血分,定经络而达荣郁。善解风邪,最调木气。升清阳之脱陷,降浊阴之冲逆,舒筋脉之急挛;利关节之壅阻。入肝胆而散遏抑,极止痛楚,通经络而开痹涩,甚去湿寒。能止奔豚,更安惊悸。”现代医学研究证实,桂枝能有效扩张血管、促进发汗,所含的桂皮醛、桂皮酸钠有解热、镇痛、镇静、抗惊厥作用,此外桂枝还有抗菌、抗病毒的功效。
太子参:味甘;微苦;性微寒。归脾、肺经。补益脾肺;益气生津。主治脾胃虚弱;食欲不振;倦怠无力;气阴两伤;干咳痰少;自汗气短;以及温病后期气虚津伤;内热口渴;或神经衰弱,心悸失眠,头昏健忘,小儿夏季热。《陕西中草药》:补气益血,健脾生津。治病后体虚,肺虚咳嗽,脾虚腹泻,小儿虚汗,心悸,口干,不思饮食。现代医学研究证明:太子参能增强机体对各种有害刺激的防御能力,还可增强人体内的物质代谢。
麦门冬:味甘;微苦;性寒。归肺;胃;心经。滋阴润肺;益胃生津;清心除烦。主治肺燥干咳;肺痈;阴虚劳嗽;津伤口渴;消渴;心烦失眠;咽喉疼痛;肠燥便秘;血热吐衄。《本草汇言》:麦门冬,清心润肺之药也。主心气不足,惊悸怔忡,健忘恍惚,精神失守;或肺热肺燥,咳声连发,肺痿叶焦,短气虚喘,火伏肺中,咯血咳血;或虚劳客热,津液干少;或脾胃燥涸,虚秘便难;此皆心肺肾脾元虚火郁之证也。然而味甘气平,能益肺金,味苦性寒,能降心火,体润质补,能养肾髓,专治劳损虚热之功居多。如前古主心腹结气,伤中伤饱,胃络脉绝,羸瘦短气等疾,则属劳损明矣。
蛤蜊粉:味咸;性寒。归肺;肾;肝经。清热;化痰利湿;软坚。主治胃痛;痰饮喘咳;水气浮肿;小便不通;遗精;白浊;崩中;带下;痈肿;瘿瘤;烫伤。《纲目》:清热利湿,化痰饮,定喘嗽.止呕逆,消浮肿,利小便,止遗精白浊,心脾疼痛,化积块,解结气,消瘿核,散肿毒,治妇人血病。油调涂汤、火伤。
丹参:味苦;性微寒;无毒。入心;肝经。活血祛瘀,通经止痛,清心除烦,凉血消痈。用于胸痹心痛,脘腹胁痛,瘕瘕积聚,热痹疼痛,心烦不眠,月经不调,痛经经闭,疮疡肿痛。《本经》载:“主心腹邪气,肠鸣幽幽如走水,寒热积聚;破症除瘕,止烦满,益气。”现代医学研究证实,丹参具有消炎止痛、扩张冠状动脉、改善心肌缺血状况、降血压、降血糖、降血脂、保肝、抗菌和促进组织的修复与再生的作用,丹参还具有抗血小板凝聚、降低血液黏度及调节内外凝血系统的功能。
豹皮菇:味甘;性平。归心;脾经。补气血;益心肝。主治气血不足;心脾两虚;疲乏无力;失眠心悸。
棒棒草:味甘;苦;性微温。补肺;健脾;养阴生津。主治肺虚咳嗽;脾虚食少;心悸自汗;疲惫乏力;口干。
柠条根:味微辛;性温。归心;肝经。益气养阴。主治:头晕,心悸,气短乏力,高血压病。
大枣:味甘;温。归脾;胃经。补脾胃;益气血;安心神;调营卫;和药性。主治脾胃虚弱;气血不足;食少便溏;倦怠乏力;心悸失眠;妇人脏躁;营卫不和。《本经》:主心腹邪气,安中养脾,助十二经。平胃气,通九窍,补少气、少津液,身中不足,大惊,四肢重,和百药。
短柄五加:益气健脾;养心安神;解郁和血。主治妇女更年期体虚乏力;潮热、失眠;抑郁不欢;健忘;心悸;头晕;头痛;关节痛。
瓜蒌:味甘苦;性寒。入肺;胃经。润肺;化痰;散结;润肠。主治痰热咳嗽;胸痹;结胸;肺痿咳血;消渴;黄疸;便秘;痈肿初起。《纲目》载:“润肺燥,降火,主胸痹,治咳嗽,涤痰结,通胸中郁热。”现代医学研究证实,瓜蒌含三萜皂苷、脂肪油、多种氨基酸和生物碱,有祛痰、扩张冠状动脉、增加冠脉流量、抗缺氧、降血脂的作用,临床上对于冠心病的治疗有较好的疗效。
延胡索:味辛;苦;性温;无毒。归肝;胃;心;肺;脾经。活血;散瘀;理气;止痛。主治心腹腰膝诸痛;月经不调;症瘕;崩中;产后血晕;恶露不尽;跌打损伤。《纲目》载:“能行血中气滞,气中血滞,故专治一身上下诸痛,用之中的,妙不可言。活血,利气,止痛,通小便。”现代医学研究表明,延胡索有显著的镇痛、镇静、催眠、安定作用,兴奋胃肠平滑肌,显著扩张冠状血管,能引起垂体促肾上腺皮质激素的分泌,对肌肉有松驰作用。
甘草:味甘;性平。归心;肺;脾;胃经。补脾益气;清热解毒;祛痰止咳;缓急止痛;调和诸药。主治脾胃虚弱;倦怠乏力;心悸气短;咳嗽痰多;脘腹四脚挛急疼痛;痈肿疮毒;缓解药物毒性。《本草纲目》载:“诸药中甘草为君。治七十二种乳石毒,解一千二百般草本毒,调和从药有功。”现代医学研究证实,甘草有较强的解毒作用,还有抗溃疡、抗炎症、镇痉镇咳、降血压、降血脂、抗癌作用,广泛用于治疗咽喉炎、喉炎、气管炎、支气管炎、哮喘、咳嗽、咳血等疾病,此外还具有抗胃溃疡、抗胃炎作用。
崖棕根:味甘;辛;性温。归肺;肝;肾经。益气养血;活血调经。主治气血虚弱;倦怠无力;心悸失眠;月经不调;经闭。
白芥子:味辛;性温。入肺;肝;脾;胃;心包经。化痰逐饮;散结消肿。主治咳喘痰多;胸满胁痛;肢体麻木;关节肿痛;湿痰流注;阴疽肿毒。《纲目》载:”利气豁痰;除寒暖中;散肿止痛。治喘嗽反胃;痹木脚气;筋骨腰节诸痛。“现代医学研究证实,白芥子有显著的抗刺激、抗菌作用,增加支气管分泌活性,祛痰。
白蒺藜:味苦;辛;性平。入肝;肺;肾;心经。平肝;解郁;祛风明目。主治头痛;眩晕;胸胁胀痛;乳房胀痛;乳闭不通;经闭;目赤翳障;风疹瘙痒;白癜风;疮疽;瘰疬。《本草便读》载:“善行善破,专入肺、肝,宣肺之滞,疏肝之淤,故能治风痹目疾。”现代医学研究表明,白蒺藜所含的蒺藜皂甙有扩张冠状动脉、改善冠状动脉循环、增强心脏收缩力、减慢心律的作用,亦能抑制血小板聚集,预防垂体后叶素及异丙肾上腺素所诱发的缺血性心电图变化,缓解心绞痛,改善心肌缺血,有抗心肌缺血和缩小心肌梗死范围的作用。
佛手:味辛;苦;性温。入肝;胃;脾;肺经。舒肝理气;和胃化痰。主治肝气郁结之胁痛;胸闷;肝胃不和;脾胃气滞之脘腹胀痛;喛气;恶心;久咳痰多。《本草再新》载:“治气舒肝,和胃化痰,破积,治噎膈反胃,消症瘕瘰疬。”现代医学研究证实,佛手有平喘祛痰作用,对抗气管收缩,迅速缓解胃、肠和胆囊的张力增加,延长惊厥发生时间,预防心律失常,增加强毛血管的抵抗力,减少肾上腺维生素C的排出,此外还有抗炎、抗微生物活性的作用。
高山露珠草:味甘;苦;性微寒。养心安神;消食;止咳;解毒;止痒。主治心悸;失眠;多梦;疳积;咳嗽;疮疡脓肿;湿疣;癣痒。
干姜:味辛;性热。归脾;胃;心;肺经。温中散寒;回阳通脉;温肺化饮。主治:脘腹冷痛;呕吐;泄泻,亡阳厥逆;寒饮喘咳;寒湿痹痛。《医学启源》:《主治秘要》云,通心气,助阳,去脏腑沉寒,发诸经之寒气,治感寒腹痛。现代医学研究发现,干姜浸剂对中枢神经、心血管系统、消化系统均有明显功效。
回心草:味淡;微苦;性平。归心经。养心安神;镇静。主治心脏病;心慌;心悸怔忡;神经衰弱。《云南思茅中草药选》:安神镇静。治心慌、心悸、心脏病。现代医学研究证明:回心草能增加冠脉血流量,改善缺血区的营养血流,并有抗血凝作用,血液粘度明显下降,且有明显的降压、降血脂作用。
莲肉:味甘;涩;性平。入心;脾;肾;胃;肝;膀胱经。补脾止泻;益肾固精;养心安神。主治脾虚久泻;久痢;肾虚遗精;滑泄;小便不禁;妇人崩漏带下;心神不宁;惊悸;不眠。《纲目》载:“交心肾,厚肠胃,固精气,强筋骨,补虚损,利耳目,除寒湿,止脾泄久痢,赤白浊,女人带下崩中诸血病,主补中,养神,益气力。”
黄花堇菜:味辛;甘;性温。归肝;脾经。温经通络;除湿止痛;消疳健脾。主治风湿痹痛;小儿麻痹后遗症;小儿疳积;气虚头晕。
灵芝:味甘苦、性平,归肺;心;脾;肾经。益气血;安心神;健脾胃。主治:虚劳;心悸;失眠;头晕;神疲乏力;久咳气喘;冠心病;矽肺;肿瘤。《神农本草经》:“赤芝,味苦平。主胸中结,益心气,补中,增慧智,不忘。现代医学研究发现,灵芝可有效地扩张冠状动脉,增加冠脉血流量,改善心肌微循环,增强心肌氧和能量的供给,因此,对心肌缺血具有保护作用,可广泛用于冠心病、心绞痛等的治疗和预防。对高血脂病患者,灵芝可明显降低血胆固醇、脂蛋白和甘油三脂,并能预防动脉粥样硬化斑块的形成。对于粥样硬化斑块已经形成者,则有降低动脉壁胆固醇含量、软化血管、防止进一步损伤的作用。
本发明与现有技术相比,具有以下有益效果:
本发明选用药材君、臣、左、使诸理皆备,药性相适相辅,针对病因对症下药,有益气养血、养阴生津、活血化瘀、温通经脉、化痰逐饮、理气解郁、清心除烦、养心安神之功效,吸收效果好,疗效显著,无毒副作用及临床不良反应,经临床验证对室性早搏治愈率较高。
具体实施方式
下面结合具体实施例对本发明做进一步阐述。
实施例1
本发明药物有效成分的原料组成及重量为:
绞股蓝69~83g、桂枝66~80g、太子参63~77g、麦门冬60~74g、
蛤蜊粉56~71g、丹参53~68g、豹皮菇50~65g、棒棒草47~62g、
柠条根44~58g、大枣41~54g、短柄五加38~51g、瓜蒌35~48g、
延胡索32~45g、甘草29~42g、崖棕根26~38g、白芥子22~35g、
白蒺藜19~32g、佛手16~28g、高山露珠草12~25g、干姜9~21g、
回心草7~18g、莲肉5~15g、黄花堇菜3~12g、灵芝1~9g。
本发明药物制备方法的工艺步骤为:
(1)将绞股蓝、桂枝、太子参、麦门冬、蛤蜊粉、豹皮菇、棒棒草、柠条根、大枣、短柄五加、瓜蒌、崖棕根、白芥子、佛手、高山露珠草、干姜、回心草、莲肉、黄花堇菜洗净、晾干后混合均匀,放入容器中,在容器中加入6~8倍量的水,加热煮沸2~3小时,冷却后取浸液;在剩余的药渣中再加入4~6倍量的水,加热煮沸1~2小时,冷却后取浸液;合并两次所得浸液,加热,蒸发浓缩为相对密度1.15~1.25的稠膏,备用;
(2)取丹参片,加黄酒拌匀,闷润至透,置锅内,用文火炒干,取出放凉,粉碎研末,过100目细筛,得细粉,备用;
(3)取净延胡索片或碎块,加黄酒拌匀,闷透,置锅内用文火加热,炒干,取出放凉,粉碎研末,过100目细筛,得细粉,备用;
(4)取净甘草片,加入炼熟的蜂蜜与少许开水,拌匀后稍闷,置炒制容器内,文火炒至深黄色,不粘手时取出,放凉,粉碎研末,过100目细筛,得细粉,备用;
(5)取去刺的白蒺藜,用盐水拌匀,闷透,置锅内用文火炒至微黄色,取出,晒干,粉碎研末,过100目细筛,得细粉,备用;
(6)将灵芝洗净晒干,粉碎研末,过100目细筛,得细粉,备用;
(7)将步骤(1)所得的稠膏,与步骤(3)、步骤(4)、步骤(5)、步骤(6)中所得的细粉混合,加辅料蔗糖和糊精混合均匀制成颗粒,干燥、整粒后,封装成每袋10g的中药冲剂。
用法用量:口服,每次1袋,每日3次,饭前半小时以开水冲服,7天为1个疗程,本中药孕妇忌服。
实施例2
本发明药物有效成分的原料组成及重量为:
绞股蓝72~80g、桂枝69~77g、太子参66~74g、麦门冬63~71g、
蛤蜊粉59~68g、丹参56~65g、豹皮菇53~62g、棒棒草50~59g、
柠条根47~55g、大枣44~51g、短柄五加41~48g、瓜蒌38~45g、
延胡索35~42g、甘草32~39g、崖棕根29~35g、白芥子25~32g、
白蒺藜22~29g、佛手19~25g、高山露珠草15~21g、干姜12~18g、
回心草9~15g、莲肉7~12g、黄花堇菜5~10g、灵芝2~7g。
本实施例的药物制备方法工艺步骤及用法用量与实施例1相同。
实施例3
本发明药物有效成分的原料组成及重量为:
绞股蓝76g、桂枝73g、太子参70g、麦门冬67g、
蛤蜊粉64g、丹参60g、豹皮菇57g、棒棒草54g、
柠条根51g、大枣48g、短柄五加44g、瓜蒌41g、
延胡索38g、甘草35g、崖棕根32g、白芥子29g、
白蒺藜26g、佛手22g、高山露珠草18g、干姜15g、
回心草12g、莲肉9g、黄花堇菜7g、灵芝4g。
本实施例的药物制备方法工艺步骤及用法用量与实施例1相同。
临床资料:
1、病例选择
选择我院收治的室性早搏患者80例临床观察,病人随机分成两组。治疗组40例,其中男性25例,女性15例,年龄32~67岁,平均年龄48.6岁,病程最短者5天,最长者2年,平均0.72年。对照组40例,其中男性25例,女性15例,年龄31~66岁,平均年龄49.4岁,病程最短者6天,最长者2年,平均0.71年。两组资历基本一致,无显著差异,具有可比性。
2、治疗组患者服用本发明药物,口服,每次1袋,每日3次,饭前半小时以开水冲服,7天为1个疗程,服用3~4个疗程。对照组根据诊断出的室性早搏的症状,对症予以美西律、β受体阻滞剂、胺碘酮等药物进行治疗手段。
3、疗效判定:
(1)治愈:临床症状消失,动态心电图显示室早消失或减少90%以上。
(2)好转:临床症状明显缓解,动态心电图显示室早减少50%~90%以上。
(3)无效:症状同施治前无明显差异,动态心电图显示室早减少少于50%。
4、结果
治疗组治愈率67.5%、总有效率92.5%,对照组治愈率60%、总有效率82.5%,两组疗效比较,差异具有统计学意义(P<0.05),故治疗组对于本病的疗效明显优于对照组。
表1两组患者临床疗效比较
典型病例举例:
1、夏××,男,45岁。该患者近1个月来,时常感觉有胸闷、心神不宁、气促的症状,来院问诊,经检查诊断为室性早搏,服用本发明中药2个疗程后,自述上述症状全部消失,来院复查动态心电图显示室早消失,已痊愈。
2、何××,女,38岁。患者患室性早搏半年,常有心悸、胸闷、气促、乏力等症状,服用西药进行治疗,病情时好时坏,未能根治,经服用本发明中药3个疗程后,上述症状明显缓解,遵医嘱继续服用本发明中药1个疗程后,上述症状完全消失,来院复查动态心电图显示室早消失,已痊愈。
目前,由于社会竞争压力大,生活节奏快,人们平时生活当中由于精神过度紧张、过度疲劳、长期失眠、进食过饱、神经衰弱、更年期等因素,以及过度吸烟、饮酒或喝浓茶等不良习惯,很容易导致室性早搏发生,不仅影响着患者的身体健康,同时也降低了患者的生活质量。临床上治疗室性早搏的方法较多,比较常见的为中医治疗和西医治疗,但是西医治疗不能治本,服药期间病情能够得到控制,但停药后会出现反复,且长期用西药治疗的副作用大,而采用中药治疗标本兼治,疗效更佳。本发明经长期临床实践,根据病因对症下药,本发明药方当中,太子参、棒棒草可补益脾肺、养阴生津;绞股蓝、柠条根可养心健脾、益气养阴;灵芝、豹皮菇、崖棕根、大枣可益气养血、调和营卫;白蒺藜、佛手可理气解郁;丹参、延胡索可活血化瘀、清心除烦;桂枝、干姜、黄花堇菜可温通经脉;白芥子、瓜蒌、蛤蜊粉可化痰逐饮、软坚散结;麦门冬可滋阴润肺、清心除烦;莲肉、短柄五加、回心草、高山露珠草可养心安神;甘草可调和诸药;方中诸药合用可共奏益气养血、养阴生津、活血化瘀、温通经脉、化痰逐饮、理气解郁、清心除烦、养心安神之功效,吸收效果好,疗效显著,无毒副作用及临床不良反应,经临床验证对室性早搏治愈率较高。
Claims (4)
1.一种用于治疗心脏室性早搏的中药饮剂,其特征在于,制成所述药物有效成分的原料组成及重量份数为:
绞股蓝69~83份、桂枝66~80份、太子参63~77份、麦门冬60~74份、
蛤蜊粉56~71份、丹参53~68份、豹皮菇50~65份、棒棒草47~62份、
柠条根44~58份、大枣41~54份、短柄五加38~51份、瓜蒌35~48份、
延胡索32~45份、甘草29~42份、崖棕根26~38份、白芥子22~35份、
白蒺藜19~32份、佛手16~28份、高山露珠草12~25份、干姜9~21份、
回心草7~18份、莲肉5~15份、黄花堇菜3~12份、灵芝1~9份。
2.根据权利要求1所述的一种用于治疗心脏室性早搏的中药饮剂,其特征在于,制成所述药物有效成分的原料组成及重量份数为:
绞股蓝72~80份、桂枝69~77份、太子参66~74份、麦门冬63~71份、
蛤蜊粉59~68份、丹参56~65份、豹皮菇53~62份、棒棒草50~59份、
柠条根47~55份、大枣44~51份、短柄五加41~48份、瓜蒌38~45份、
延胡索35~42份、甘草32~39份、崖棕根29~35份、白芥子25~32份、
白蒺藜22~29份、佛手19~25份、高山露珠草15~21份、干姜12~18份、
回心草9~15份、莲肉7~12份、黄花堇菜5~10份、灵芝2~7份。
3.根据权利要求1所述的一种用于治疗心脏室性早搏的中药饮剂,其特征在于,制成所述药物有效成分的原料组成及重量份数为:
绞股蓝76份、桂枝73份、太子参70份、麦门冬67份、
蛤蜊粉64份、丹参60份、豹皮菇57份、棒棒草54份、
柠条根51份、大枣48份、短柄五加44份、瓜蒌41份、
延胡索38份、甘草35份、崖棕根32份、白芥子29份、
白蒺藜26份、佛手22份、高山露珠草18份、干姜15份、
回心草12份、莲肉9份、黄花堇菜7份、灵芝4份。
4.根据权利要求1~3所述的一种用于治疗心脏室性早搏的中药饮剂的制备方法,其特征在于,包括以下工艺步骤:
(1)将绞股蓝、桂枝、太子参、麦门冬、蛤蜊粉、豹皮菇、棒棒草、柠条根、大枣、短柄五加、瓜蒌、崖棕根、白芥子、佛手、高山露珠草、干姜、回心草、莲肉、黄花堇菜洗净、晾干后混合均匀,放入容器中,在容器中加入6~8倍量的水,加热煮沸2~3小时,冷却后取浸液;在剩余的药渣中再加入4~6倍量的水,加热煮沸1~2小时,冷却后取浸液;合并两次所得浸液,加热,蒸发浓缩为相对密度1.15~1.25的稠膏,备用;
(2)取丹参片,加黄酒拌匀,闷润至透,置锅内,用文火炒干,取出放凉,粉碎研末,过100目细筛,得细粉,备用;
(3)取净延胡索片或碎块,加黄酒拌匀,闷透,置锅内用文火加热,炒干,取出放凉,粉碎研末,过100目细筛,得细粉,备用;
(4)取净甘草片,加入炼熟的蜂蜜与少许开水,拌匀后稍闷,置炒制容器内,文火炒至深黄色,不粘手时取出,放凉,粉碎研末,过100目细筛,得细粉,备用;
(5)取去刺的白蒺藜,用盐水拌匀,闷透,置锅内用文火炒至微黄色,取出,晒干,粉碎研末,过100目细筛,得细粉,备用;
(6)将灵芝洗净晒干,粉碎研末,过100目细筛,得细粉,备用;
(7)将步骤(1)所得的稠膏,与步骤(3)、步骤(4)、步骤(5)、步骤(6)中所得的细粉混合,加辅料蔗糖和糊精混合均匀制成颗粒,干燥、整粒后,封装成每袋10g的中药冲剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610239725.5A CN105797106A (zh) | 2016-04-18 | 2016-04-18 | 一种用于治疗心脏室性早搏的中药饮剂及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610239725.5A CN105797106A (zh) | 2016-04-18 | 2016-04-18 | 一种用于治疗心脏室性早搏的中药饮剂及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105797106A true CN105797106A (zh) | 2016-07-27 |
Family
ID=56460319
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610239725.5A Withdrawn CN105797106A (zh) | 2016-04-18 | 2016-04-18 | 一种用于治疗心脏室性早搏的中药饮剂及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105797106A (zh) |
-
2016
- 2016-04-18 CN CN201610239725.5A patent/CN105797106A/zh not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103860969A (zh) | 一种增肥的中药 | |
CN105194565A (zh) | 一种用于治疗心脏神经症的中药丸剂及制备方法 | |
CN105687824A (zh) | 一种用于治疗产后盗汗的中药冲剂及制备方法 | |
CN102670966A (zh) | 一种治疗扩张型心肌病的中药组合物 | |
CN104524335A (zh) | 一种用于女性内分泌失调调理的药丸及制备方法 | |
CN105148039A (zh) | 一种用于缓解肿瘤放疗后反应的中药药丸及制备方法 | |
CN106880826A (zh) | 一种治疗慢性心力衰竭的中药制剂及其制备方法 | |
CN104083728B (zh) | 抗癌消瘤浓缩丸的加工方法 | |
CN104771729A (zh) | 一种用于肺癌辅助治疗的中药丸剂及制备方法 | |
CN105833172A (zh) | 用于治疗无症状性心肌缺血的中药冲剂及制备方法 | |
CN105687738A (zh) | 一种用于治疗顽固性咳嗽的中药冲剂及制备方法 | |
CN105456661A (zh) | 一种用于治疗放射性皮炎的中药冲剂及制备方法 | |
CN103169905B (zh) | 治疗肺心病的中药制剂胶囊及其制备方法 | |
CN105688002A (zh) | 一种用于治疗老年功能性便秘的中药冲剂及制备方法 | |
CN105343866A (zh) | 一种用于治疗寒饮咳嗽的中药片剂及制备方法 | |
CN104826074A (zh) | 一种用于窦性心动过缓的中药制剂及其制备方法 | |
CN103845671B (zh) | 心力衰竭温阳益气散及制备方法 | |
CN105797106A (zh) | 一种用于治疗心脏室性早搏的中药饮剂及制备方法 | |
CN103720870B (zh) | 一种治疗心肌炎症的中药制剂及制备方法 | |
CN107737282A (zh) | 一种治疗肝部癌症的药剂 | |
CN102614436B (zh) | 治疗肺心病的中药制剂及其制备方法 | |
CN103169907B (zh) | 治疗肺心病的中药制剂片剂及其制备方法 | |
CN102670773A (zh) | 一种治疗硬皮症的中药制剂 | |
CN104857415A (zh) | 一种胃癌患者服用的糯米粥及制法 | |
CN105125786A (zh) | 一种用于治疗乳腺增生的中药制剂及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160727 |